Back to top
more

ColgatePalmolive (CL)

(Delayed Data from NYSE)

$96.49 USD

96.49
4,257,936

-0.11 (-0.11%)

Updated Jul 25, 2024 04:00 PM ET

After-Market: $96.50 +0.01 (0.01%) 6:36 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 27% (182 out of 250)

Industry: Soap and Cleaning Materials

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Factors Likely to Influence Hershey's (HSY) Q3 Earnings

by Zacks Equity Research

The Hershey Company's (HSY) third-quarter performance is likely to reflect gains from solid demand and pricing actions. Prudent buyouts have also been a driver.

Columbia Sportswear (COLM) Readies for Q3 Earnings: What Awaits?

by Zacks Equity Research

Columbia Sportswear's (COLM) third-quarter results are likely to reflect gains from the DTC channel and brand strength amid high SG&A costs.

Chef's Warehouse (CHEF) Q3 Earnings Coming Up: What to Expect

by Zacks Equity Research

Chef's Warehouse's (CHEF) third-quarter 2023 sales results are likely to reflect gains from the sturdy execution of its strategic and expansion initiatives.

Colgate-Palmolive (CL) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Colgate-Palmolive (CL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

What to Know About Altria (MO) as It Queues for Q3 Earnings?

by Zacks Equity Research

Altria's (MO) third-quarter results are likely to reflect gains from pricing and strength in oral tobacco products amid soft cigarette volumes.

Can Keurig Dr Pepper (KDP) Beat on Q3 Earnings Amid Inflation?

by Zacks Equity Research

Keurig Dr Pepper's (KDP) Q3 results are expected to reflect gains from continued brand strength, significant pricing actions, a solid performance in its cold beverages and strong market share gains.

Brand Strength & Pricing to Aid Boston Beer's (SAM) Q3 Earnings

by Zacks Equity Research

Boston Beer's (SAM) Q3 results are expected to reflect the momentum in the Twisted Tea brand, innovation, its intensified attention to pricing and product portfolio expansion efforts.

Can Archer Daniels (ADM) Retain Its Earnings Beat Trend in Q3?

by Zacks Equity Research

A solid product portfolio, improved crush margins and resilient food demand are likely to aid Archer Daniels' (ADM) Q3 results amid inflation challenges and a soft Nutrition segment performance.

Can Coca-Cola (KO) Q3 Earnings Beat Countering Inflation Woes?

by Zacks Equity Research

Coca-Cola's (KO) Q3 results are likely to reflect the benefits of strength across markets, and gains from innovations and accelerating digital investments, offset by inflationary pressures and higher SG&A.

Simply Good Foods (SMPL) Q4 Earnings Coming Up: What to Expect

by Zacks Equity Research

Simply Good Foods' (SMPL) fourth-quarter fiscal 2023 results are likely to reflect gains from brand-building initiatives and cost-controlling efforts.

Want Better Returns? Don?t Ignore These 2 Consumer Staples Stocks Set to Beat Earnings

by Zacks Equity Research

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Procter & Gamble (PG) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

P&G (PG) delivered earnings and revenue surprises of 7.02% and 1.03%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Will Smoke-Free Products Fuel Philip Morris' (PM) Q3 Earnings?

by Zacks Equity Research

Philip Morris (PM) benefits from strength in the smoke-free product unit due to consumers' growing inclination toward health and wellness.

What Awaits Philip Morris (PM) as It Queues for Q3 Earnings?

by Zacks Equity Research

Philip Morris' (PM) third-quarter results are likely to reflect gains from pricing as well as strength in smoke-free products amid soft cigarette volumes.

Will Colgate-Palmolive (CL) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Colgate-Palmolive (CL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will Demand & Pricing Trends Aid PepsiCo's (PEP) Q3 Earnings?

by Zacks Equity Research

PepsiCo's (PEP) Q3 results are expected to have gained from strong demand, improved pricing, strength in its beverage and food businesses, and gains from cost- and revenue-management initiatives.

What Awaits Conagra Brands (CAG) as It Queues for Q1 Earnings?

by Zacks Equity Research

Conagra Brands' (CAG) first-quarter results are likely to reflect gains from the frozen and snacks categories. Solid pricing efforts are likely to aid amid cost inflation.

P&G (PG) Gains From Solid Product Portfolio, Pricing Actions

by Zacks Equity Research

Procter & Gamble (PG) stays afloat in a tough environment, thanks to its product portfolio, pricing actions, and productivity and cost-saving plans.

Ritujay Ghosh headshot

Consumer Confidence Plummets on Recession Fears: 5 Stocks to Buy

by Ritujay Ghosh

Consumer confidence is declining on recession fears. Defensive stocks like ALLETE (ALE), Consolidated Water (CWCO), American Water Works Company (AWK), Kimberly-Clark (KMB) and Colgate-Palmolive (CL) are safe bets.

Will Colgate's (CL) Innovation Efforts Boost Its Stock?

by Zacks Equity Research

Colgate (CL) suffers from rising raw material costs and inflation, as well as the impacts of pricing actions. Its innovation and expansion efforts place it well for growth in the long term.

The Zacks Analyst Blog Highlights Visa, Chubb, HCA Healthcare, Colgate-Palmolive and Veeva

by Zacks Equity Research

Visa, Chubb, HCA Healthcare, Colgate-Palmolive and Veeva are included in this Analyst Blog.

Sheraz Mian headshot

Top Stock Reports for Visa, Chubb & HCA Healthcare

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Chubb Limited (CB) and HCA Healthcare, Inc. (HCA).

Can Its Growth Efforts Aid Colgate (CL) Amid Cost Woes?

by Zacks Equity Research

Despite rising raw material costs and adverse currency, Colgate's (CL) robust innovation, pricing efforts and expansion plans are likely to drive growth in the long term.

The Zacks Analyst Blog Highlights Visa, Novo Nordisk, Medtronic, Shopify and Colgate-Palmolive

by Zacks Equity Research

Visa, Novo Nordisk, Medtronic, Shopify and Colgate-Palmolive are included in this Analyst Blog.

Sheraz Mian headshot

Top Stock Reports for Visa, Novo Nordisk & Medtronic

by Sheraz Mian

Today's Research Daily features new research reports on 12 major stocks, including Visa Inc. (V), Novo Nordisk A/S (NVO) and Medtronic plc (MDT).